Biotech · Private company · San Diego, CA, US

Versapeutics Inc

Track this companyFree. Adds Versapeutics Inc to your Dealase workspace and tells you when its record changes.

Clinical trials0None registered

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

NIH awards2

Preclinical Toxicology Study of Intrathecal VersaMab-101 for spinal cord injury treatmentFiscal year 2025 · $1.5MNIH RePORTER 5R44NS127712-03 · fetched Nov 12, 2026
Preclinical Toxicology Study of Intrathecal VersaMab-101 for spinal cord injury treatmentFiscal year 2024 · $1.4MNIH RePORTER 2R44NS127712-02 · fetched Nov 12, 2026